Rigel gets 5M & some good news from Pfizer:
…Pfizer (NYSE: PFE), has begun a Phase 1 clinical trial of an inhaled formulation of Rigel’s small molecule syk kinase inhibitor, R343, for the treatment of allergic asthma…
Archive for December 7th, 2007
R-343
Posted by kinasepro on December 7, 2007
Posted in Pfizer, Rigel, SYK | 2 Comments »
TG-101348
Posted by kinasepro on December 7, 2007
Targegen’s got a press release:
Plans to initiate a multi-center clinical trial of TG101348, an internally discovered, oral, potent, and highly selective JAK2 inhibitor in January, 2008
A poster at ASH:
…Dual-Acting JAK2/FLT3 Small Molecule Kinase Inhibitor for the Treatment of AML
and some pyrimidines in WO/2007/053452:
Posted in biotech, clinical, Flt3, JAK | Leave a Comment »
KinasePro 